Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: A potential solution to cell-based cardiac repair

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 6, 2014, Pages 1236-1238

  Zhang, Shuning ^a   Ma, Xin ^a   Yao, Kang ^a   Zhu, Hong ^a   Huang, Zheyong ^a   Shen, Li ^a   Qian, Juying ^a   Zou, Yunzeng ^a   Sun, Aijun ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CD34 positive cells; Endothelial cell lineage; Matrix stiffness; Myocardial infarction

Indexed keywords

CD34 ANTIGEN;

ANGIOGENESIS; BIOLOGICAL THERAPY; HEART MUSCLE; HUMAN; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WOUND HEALING;

ANTIGENS, CD34; CELL- AND TISSUE-BASED THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; WOUND HEALING;

EID: 84904749754     PISSN: 15821838     EISSN: 15824934     Source Type: Journal    
DOI: 10.1111/jcmm.12301     Document Type: Article

References (27)

1. Vilahur G, Juan-Babot O, Pena E, et al. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol. 2011; 50: 522-33.
2. Ii M. Bone marrow-derived endothelial progenitor cells: isolation and characterization for myocardial repair. Methods Mol Biol. 2010; 660: 9-27.
3. Hisatome T, Yasunaga Y, Yanada S, et al. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. Biomaterials. 2005; 26: 4550-6.
4. Ryu JH, Kim IK, Cho SW, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials. 2005; 26: 319-26.
5. Zhang SN, Sun AJ, Ge JB, et al. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol. 2009; 136: 178-85.
6. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007; 49: 741-52.
7. Manole CG, Cismasiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011; 15: 2284-96.
8. Yang J, Ii M, Kamei N, et al. CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow. PLoS ONE. 2011; 6: e20219.
9. Lee JH, Lee SH, Yoo SY, et al. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases. Arterioscler Thromb Vasc Biol. 2013; 33: 1622-34.
10. Alev C, Ii M, Asahara T. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal. 2011; 15: 949-65.
11. Mackie AR, Losordo DW. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J. 2011; 38: 474-85.
12. Nonaka-Sarukawa M, Yamamoto K, Aoki H, et al. Circulating endothelial progenitor cells in congestive heart failure. Int J Cardiol. 2007; 119: 344-8.
13. Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012; 348: 265-79.
14. Zhao B, Chen S, Liu J, et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013; 17: 123-33.
15. Arshi A, Nakashima Y, Nakano H, et al. Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells. Sci Technol Adv Mater. 2013; 14: pii: 025003.
16. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
17. Alaiti MA, Ishikawa M, Masuda H, et al. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med. 2012; 16: 2413-21.
18. Michel G, Tonon T, Scornet D, et al. The cell wall polysaccharide metabolism of the brown alga Ectocarpus siliculosus. Insights into the evolution of extracellular matrix polysaccharides in Eukaryotes. New Phytol. 2010; 188: 82-97.
19. Bani D, Nistri S. New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. lessons from the heart. J Cell Mol Med. 2014; 18: 363-70.
20. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009; 324: 1673-7.
21. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature. 2009; 462: 433-41.
22. Engler AJ, Sen S, Sweeney HL, et al. Matrix elasticity directs stem cell lineage specification. Cell. 2006; 126: 677-89.
23. Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006; 290: H2196-203.
24. Bartunek J, Wijns W, Heyndrickx GR, et al. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006; 3(Suppl. 1): S52-6.
25. Zhang S, Sun A, Xu D, et al. Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol. 2009; 32: 458-66.
26. Zhang S, Sun A, Liang Y, et al. A role of myocardial stiffness in cell-based cardiac repair: a hypothesis. J Cell Mol Med. 2009; 13: 660-3.
27. Zhang S, Sun A, Ma H, et al. Infarcted myocardium-like stiffness contributes to endothelial progenitor lineage commitment of bone marrow mononuclear cells. J Cell Mol Med. 2011; 15: 2245-61.